Rule 4729:7-1-01 | Compounding references.
As used in this division and in agency 4729 of the Administrative Code:
(A) "The national institute for occupational safety and health's list of antineoplastic and other hazardous drugs in healthcare settings" means publication number 2025-103 (December 2024).
(B) "United States Pharmacopeia Chapter <795>" or "USP <795>" means United States Pharmacopeia Chapter <795> (November 1, 2023).
(C) "United States Pharmacopeia Chapter <797>" or "USP <797>" means United States Pharmacopeia Chapter <797> (November 1, 2023).
(D) "United States Pharmacopeia Chapter <800>" or "USP <800>" means United States Pharmacopeia Chapter <800> (December 1, 2022).
(E) The board may grant an existing licensee a temporary extension to the requirements to comply with the standards listed in paragraphs (B) and (C) of this rule if the licensee can demonstrate all of the following:
(1) The licensee was compliant with the standards in effect immediately prior to the effective date of this rule;
(2) Significant hardship in meeting the standards; and
(3) Sufficient progress towards compliance with the standards.
Last updated March 2, 2026 at 8:35 AM